Literature DB >> 6736987

Pneumonitis, pleural effusion and pericarditis following treatment with dantrolene.

D H Miller, L F Haas.   

Abstract

A patient developed pulmonary infiltration, pleural effusions and pericarditis three months after starting dantrolene sodium. Peripheral blood eosinophilia and a raised ESR were present. Symptoms and signs resolved after the drug was discontinued. Dantrolene toxicity should be considered in the differential diagnosis of pneumonitis and pleuro-pericarditis.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6736987      PMCID： PMC1027836          DOI： 10.1136/jnnp.47.5.553

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  8 in total

1.  Letter: practolol-induced pleurisy and constrictive pericarditis.

Authors:  N H Dyer; C C Varley
Journal:  Br Med J       Date:  1975-05-24

2.  Procainamide-induced systemic lupus erythematosus.

Authors:  E T Swarbrick; I R Gray
Journal:  Rheumatol Rehabil       Date:  1973-05

3.  Chronic nitrofurantoin pulmonary reaction. Report of 5 cases.

Authors:  E C Rosenow; R A DeRemee; D E Dines
Journal:  N Engl J Med       Date:  1968-12-05       Impact factor: 91.245

4.  Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants.

Authors:  B H Singsen; L Fishman; V Hanson
Journal:  Pediatrics       Date:  1976-04       Impact factor: 7.124

5.  Dantrolene-associated hepatic injury. Incidence and character.

Authors:  R Utili; J K Boitnott; H J Zimmerman
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

6.  Pleural effusion and fibrosis during treatment with methysergide.

Authors:  W Hindle; E Posner; M T Sweetnam; R S Tan
Journal:  Br Med J       Date:  1970-03-07

7.  Pleuropericardial reaction to treatment with dantrolene.

Authors:  M L Petusevsky; L J Faling; R E Rocklin; G L Snider; A D Merliss; J M Moses; S A Dorman
Journal:  JAMA       Date:  1979-12-21       Impact factor: 56.272

8.  Recent advances in the treatment of Parkinson's disease: the role of bromocriptine.

Authors:  P A Le Witt; D B Calne
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575
  8 in total
  2 in total

Review 1.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

Review 2.  Acetaminophen poisoning-induced heart injury: a case-based review.

Authors:  Fatemeh KhabazianZadeh; Tooba Kazemi; Samaneh Nakhaee; Patrick C Ng; Omid Mehrpour
Journal:  Daru       Date:  2019-11-11       Impact factor: 3.117
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.